OpenURL Connection Search

Select item for more details and to access through your institution.

Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma.
Published in:
1999
By:
- Friedberg, Jonathan W.;
- Van den Abbeele, Annick D.;
- Kehoe, Kathleen;
- Singer, Samuel;
- Fletcher, Christopher D.;
- Demetri, George D.;
- Friedberg, J W;
- Van den Abbeele, A D;
- Kehoe, K;
- Singer, S;
- Fletcher, C D;
- Demetri, G D
Publication type:
journal article
Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.
Published in:
Bone Marrow Transplantation, 2003, v. 32, n. 7, p. 681, doi. 10.1038/sj.bmt.1704212
By:
- Friedberg, J W;
- Kim, H;
- Li, S;
- Neuberg, D;
- Boyd, K;
- Daley, H;
- Fisher, D C;
- Gribben, J G;
- Spitzer, T;
- Freedman, A S
Publication type:
Article
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2013, v. 27, n. 8, p. 1769, doi. 10.1038/leu.2013.37
By:
- Herman, S E M;
- Barr, P M;
- McAuley, E M;
- Liu, D;
- Wiestner, A;
- Friedberg, J W
Publication type:
Article
PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS.
Published in:
Hematological Oncology, 2023, v. 41, p. 848, doi. 10.1002/hon.3166_OT27
By:
- Brem, E. A.;
- Li, H.;
- Beaven, A. W.;
- Caimi, P.;
- Cerchietti, L.;
- Olin, R. L.;
- Henry, N. L.;
- Dilon, H.;
- Little, R. F.;
- Leblanc, M. L.;
- Kahl, B.;
- Leonard, J. P.;
- Friedberg, J. W.;
- Smith, S. M.
Publication type:
Article
SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 839, doi. 10.1002/hon.3166_OT19
By:
- Hess, B.;
- Li, H.;
- Hossain, N.;
- Beylergil, V.;
- Sauter, C.;
- Hamadani, M.;
- Svoboda, J.;
- Major, A.;
- Kahl, B.;
- Leonard, J. P;
- Smith, S.;
- LeBlanc, M.;
- Stiff, P.;
- Friedberg, J. W
Publication type:
Article
S2207: RANDOMIZED PHASE II STUDY OF THE ADDITION OF TARGETED AGENTS TO TAFASITAMAB‐LENALIDOMIDE IN TRANSPLANT INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LBCL.
Published in:
Hematological Oncology, 2023, v. 41, p. 842, doi. 10.1002/hon.3166_OT22
By:
- Amengual, J. E.;
- Reagan, P.;
- Li, H.;
- Saeed, H.;
- Vaidya, R.;
- Unger, J. M.;
- Danilov, A.;
- LeBlanc, M.;
- Friedberg, J. W.;
- Smith, S. M.
Publication type:
Article
A "FUNCTIONAL CURE" MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016.
Published in:
Hematological Oncology, 2023, v. 41, p. 116, doi. 10.1002/hon.3163_79
By:
- Shadman, M.;
- Li, H.;
- Rimsza, L.;
- Leonard, J. P.;
- Kaminski, M. S;
- Spier, C. M;
- Gopal, A. K;
- Dakhil, S.;
- LeBlanc, M.;
- Smith, S. M.;
- Friedberg, J. W
Publication type:
Article
Phase 1 trial of EO2463 peptide‐based immunotherapy as monotherapy and in combination with lenalidomide and rituximab in indolent non‐Hodgkin lymphoma; EONHL1‐20/SIDNEY.
Published in:
Hematological Oncology, 2023, v. 41, p. 581, doi. 10.1002/hon.3164_435
By:
- Pinto, A. A.;
- Bosch, F.;
- Bisneto, J. C. Villasboas;
- Sanz, R. García;
- Garcia, C. Grande;
- Smith, S. D.;
- Wallace, D. S.;
- Arcaini, L.;
- Merryman, R.;
- Marolleau, J.;
- De Filippi, R.;
- Chêne, L.;
- Bonny, C.;
- Fagerberg, J.;
- Friedberg, J. W.;
- Ansel, S.;
- Armand, P.;
- Zinzani, P. L.
Publication type:
Article
Venetoclax based combination therapy does not overcome poor outcomes in BTKi‐refractory mantle cell lymphoma: phase 2 trial of umbralisib, ublituximab, and venetoclax.
Published in:
Hematological Oncology, 2023, v. 41, p. 484, doi. 10.1002/hon.3164_356
By:
- Wallace, D. S.;
- Rowland, C.;
- Hill, B. T.;
- Baran, A. M.;
- Casulo, C.;
- Reagan, P. M.;
- Winter, A.;
- Karmali, R.;
- Winter, J. N.;
- Gordon, L. I.;
- Bui, A.;
- Sportelli, P.;
- Weiss, M. S.;
- Miskin, H. P.;
- Friedberg, J. W.;
- Ma, S.;
- Barr, P. M.
Publication type:
Article
Patient‐ versus clinician‐reported symptoms in the POLARIX study.
Published in:
Hematological Oncology, 2023, v. 41, p. 414, doi. 10.1002/hon.3164_305
By:
- Thompson, C. A.;
- Mehta‐Shah, N.;
- Flowers, C.;
- Salles, G.;
- Tilly, H.;
- Chua, N.;
- Casasnovas, R.;
- Miall, F.;
- Kim, T. M.;
- Tsai, C.;
- Nasta, S.;
- Lee, S. T.;
- Craine, V.;
- Campinha‐Bacote, A.;
- Hirata, J.;
- Lee, C.;
- Sugidono, M.;
- Friedberg, J. W.
Publication type:
Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 175, doi. 10.1002/hon.3163_111
By:
- Herrera, A. F.;
- Tracy, S.;
- Sehn, L. H.;
- Jardin, F.;
- Lenz, G.;
- Trněný, M.;
- Salles, G.;
- Flowers, C. R.;
- Tilly, H.;
- Sharman, J. P.;
- Friedberg, J. W.;
- Balasubramanian, S.;
- Raghavan, V.;
- Hirata, J.;
- Lee, C.;
- Jiang, Y.;
- Morschhauser, F.
Publication type:
Article
NEW PROGNOSTIC SCORE INCORPORATING MTV PREDICTS TREATMENT FAILURE IN ADVANCED HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.73_2879
By:
- Barrington, S. F.;
- Kirkwood, A. A.;
- Pike, L. C.;
- Guezennec, C.;
- Li, H.;
- le Blanc, M.;
- Poon, D.;
- Knopp, M. V.;
- Clifton‐Hadley, L.;
- Laubach, C.;
- Schöder, H.;
- Friedberg, J. W.;
- Johnson, P. W.
Publication type:
Article

Found: 12